Johnson & Johnson snares FDA nod for first exon 20-targeted drug in EGFR lung cancer May 21, 2021 Auto Bot News 0 Johnson & Johnson snares FDA nod for first exon 20-targeted drug in EGFR lung cancer fkansteiner Fri, 05/21/2021 – 14:38
